Though ours is the first to identify methylation reprogramming of the PI3K and R/R/C pathways in ADM, previous studies have also examined the behavior of PI3K and R/R/C in pancreatic cancer, although those studies involved oncogenic mutations. The gene discussed is PIK3CB; the disease is pancreatic neoplasm.